5.86
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RXRX Giù?
Forum
Previsione
Recursion Pharmaceuticals Inc Borsa (RXRX) Ultime notizie
Great Week for Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Institutional Investors After Losing 2.9% Over the Previous Year - 富途牛牛
Why Recursion Pharmaceuticals, Inc. (RXRX) Surged On Friday? - MSN
Recursion Pharmaceuticals (RXRX) Suffers a Larger Drop Than the General Market: Key Insights - Nasdaq
Recursion (RXRX) Stock Surges on AI-Driven Breakthroughs and Big-Pharma Deals - ts2.tech
RXRX Stock’s Surprising Journey: A Closer Look - timothysykes.com
Recursion Pharmaceuticals (RXRX) Extends Gains, Jumps 15.28% on Major AI Event - MSN
Is Recursion Pharmaceuticals a Millionaire Maker? - Yahoo Finance
Recursion Pharma (RXRX) Stock Jumps as AI Drug Discovery Hype Builds - parameter.io
Recursion Pharmaceuticals’ Stock Soars Amid Investor Optimism - TipRanks
Will Recursion Pharmaceuticals Inc. stock maintain growth storyEarnings Growth Report & High Return Stock Watch Alerts - newser.com
Recursion RXRX Stock Skyrockets: AI Breakthroughs and Big Pharma Deals Ignite Biotech Surge - ts2.tech
When is the best time to exit Recursion Pharmaceuticals Inc.Market Movers & Real-Time Buy Zone Alerts - newser.com
RXRX’s Big Leap: Worries Over? - StocksToTrade
Evaxion (NASDAQ:EVAX) Stock Rockets After AI-Powered Cancer Vaccine Breakthrough - ts2.tech
Recursion Pharmaceuticals Inc. stock volume spike explained2025 Key Lessons & Step-by-Step Trade Execution Guides - newser.com
Signal strength of Recursion Pharmaceuticals Inc. stock in tech scannersTrade Performance Summary & AI Forecast for Swing Trade Picks - newser.com
Best Biotech Stocks To Follow NowOctober 10th - MarketBeat
How to recover losses in Recursion Pharmaceuticals Inc. stock2025 Breakouts & Breakdowns & Verified Entry Point Detection - newser.com
Recursion Surge: Is Now the Perfect Time to Consider? - timothysykes.com
Recursion Pharmaceuticals Stock (RXRX) Opinions on Recent Price Momentum - Quiver Quantitative
Absci Stock Offers High-Risk AI Biotech Exposure With 110% Upside Forecast - Investing.com
Will Recursion Pharmaceuticals Inc. stock recover faster than marketWall Street Watch & Low Risk Entry Point Guides - newser.com
Advanced analytics toolkit walkthrough for Recursion Pharmaceuticals Inc.Weekly Market Report & Daily Profit Maximizing Trade Tips - newser.com
Is Recursion Pharmaceuticals on a Comeback Trail? - StocksToTrade
Best Biotech Stocks To ConsiderOctober 9th - MarketBeat
Biotech Stocks To ResearchOctober 13th - MarketBeat
Using economic indicators to assess Recursion Pharmaceuticals Inc. potentialJuly 2025 Patterns & Free Fast Entry Momentum Trade Alerts - newser.com
Recursion Pharmaceuticals Hits Day High with 16.44% Surge in Stock Price - Markets Mojo
Costco, AMD, Recursion Pharmaceuticals, Cipher Mining And Snowflake: Why These 5 Stocks Are On Investors' Radars Today - AOL.com
Promising Biotech Stocks To Follow NowOctober 11th - MarketBeat
Recursion Pharmaceuticals (RXRX): Assessing Valuation with AI Strategy in Focus Ahead of Key CEO Presentation - Yahoo Finance
Where Will Recursion Pharmaceuticals Be in 5 Years? - MSN
How Investors Are Reacting To Recursion Pharmaceuticals (RXRX) AI Platform Spotlight Ahead of CEO's Dubai Talk - simplywall.st
Recursion Pharmaceuticals, Inc.Class A Common Stock (NQ: RXRX - FinancialContent
Biotech Stocks To Follow TodayOctober 8th - MarketBeat
RXRX Stock: What’s Behind Recent Moves? - timothysykes.com
Recursion Pharmaceuticals (RXRX): Evaluating Valuation Ahead of CEO’s AI Conference Appearance and Growth Plans - simplywall.st
Recursion (RXRX) insider sales include 100,000-share Form 144 notice - Stock Titan
Recursion Stock: Can It Bounce Back? - StocksToTrade
Recursion Pharmaceuticals’ Stocks: A Deep Dive - timothysykes.com
Assessing Recursion Pharmaceuticals After Shares Surge 19% Amid AI-Driven Market Optimism - simplywall.st
Recursion Pharmaceuticals: Recent Gains Mysterious Given Lack Of Overall Progress (RXRX) - Seeking Alpha
AI Drug Discovery Goldmine? Inside Recursion Pharma’s Wild Stock Surge and What’s Next - ts2.tech
Weiss Ratings Reiterates "Sell (D-)" Rating for Recursion Pharmaceuticals (NASDAQ:RXRX) - MarketBeat
Recursion Pharmaceuticals (RXRX) Climbs 16% Ahead of AI Conference - Yahoo Finance
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):